Altered oxidant-antioxidant levels in the disease prognosis of chronic obstructive pulmonary disease

International Journal of Tuberculosis and Lung Disease

Volumn 17, Issue 8, 2013, Pages 1104-1109

  Ahmad, A ^a,b   Shameem, M ^b   Husain, Qayyum ^a  

^a ALIGARH MUSLIM UNIVERSITY   (India)

^b ALIGARH MUSLIM UNIVERSITY   (India)

Author keywords

Antioxidants; COPD; Oxidative stress; Reactive oxygen species

Indexed keywords

ANTIOXIDANT; CARBONYL DERIVATIVE; CATALASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; OXIDIZING AGENT; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THIOL GROUP;

ADULT; ARTICLE; CHEMICAL PARAMETERS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME ACTIVITY; FEMALE; FERRIC ION REDUCING ANTIOXIDANT POWER; FORCED EXPIRATORY VOLUME; HUMAN; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL;

ADULT; ANTIOXIDANTS; CASE-CONTROL STUDIES; CATALASE; DISEASE PROGRESSION; FEMALE; FORCED EXPIRATORY VOLUME; GLUTATHIONE PEROXIDASE; HUMANS; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDANTS; OXIDATIVE STRESS; PROGNOSIS; PROTEIN CARBONYLATION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; SULFHYDRYL COMPOUNDS; SUPEROXIDE DISMUTASE;

EID: 84880459273     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.12.0512     Document Type: Article

References (35)

1. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. ATS Statement. Am J Respir Crit Care Med 1995; 152 (Suppl): S77-S121.
2. Hogg J C, Chu F, Utokaparch S, Woods R, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004; 350: 2645-2653. (Pubitemid 38787999)
3. Soriano J B, Rodriguez-Roisin R. Chronic obstructive pulmonary disease overview: epidemiology, risk factors, and clinical presentation. Proc Am Thorac Soc 2011; 8: 363-367.
4. Rahman I, Morrison D, Donaldson K, MacNee W. Systemic oxidative stress in asthma, COPD, and smokers. Am J Respir Crit Care Med 1996; 154: 1055-1060.
5. Rahman I, Swarska E, Henry M, Stolk J, MacNee W. Is there any relationship between plasma antioxidant capacity and lung function in smokers and in patients with chronic obstructive pulmonary disease? Thorax 2000; 55: 189-193. (Pubitemid 30245967)
6. Ahmad A, Shameem M, Husain Q. Relation of oxidant- antioxidant imbalance with disease progression in patients with asthma. Ann Thorac Med 2012; 7: 226-232.
7. MacNee W. Pathogenesis of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005; 2: 258-266. (Pubitemid 41566933)
8. Rajendrasozhan S, Yao H, Rahman I. Current perspectives on role of chromatin modifications and deacetylases in lung inflammation in COPD. COPD 2009; 6: 291-297.
9. Heffner J E, Repine J E. Antioxidants and the lung. In: Crystal R G, West W B, eds. The lung: scientific foundations. New York, NY, USA: Raven Press, 1991: pp 1811-1820.
10. Tavilani H, Nadi E, Karimi J, Goodarzi M T. Oxidative stress in COPD patients, smokers, and non-smokers. Respir Care 2012; 57: 2090-2094.
11. Ahmad A, Shameem M, Husain Q. Correlation of exhaled carbon monoxide and nitric oxide with airflow obstruction in asthma and chronic obstructive pulmonary disease patients. Ann Biol Res 2012; 3: 1672-1678.
12. Tsukagoshi H, Shimizu Y, Iwamae S, et al. Evidence of oxidative stress in asthma and COPD: potential inhibitory effect of theophylline. Respir Med 2000; 94: 584-588. (Pubitemid 30599239)
13. Drost E M, Skwarski K M, Sauleda J, et al. Oxidative stress and airway inflammation in severe exacerbations of COPD. Thorax 2005; 60: 293-300. (Pubitemid 40522365)
14. Pratico D, Basili S, Vieri M, Cordova C, Violi F, FitzGerald G A. Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2α-III, an index of oxidant stress. Am J Respir Crit Care Med 1998; 158: 1709-1714. (Pubitemid 29008804)
15. Rabe K F, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176: 532-555. (Pubitemid 47403272)
16. Buege J A, Aust S D. Microsomal lipid peroxidation. Methods Enzymol 1978; 52: 302-310.
17. Levine R L, Williams J A, Stadtman E R, Schacter E. Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol 1994; 233: 346-357.
18. Sedalk J, Lindsay R H. Estimation of total, protein-bound and non-protein sulfhydryl groups in tissues with Ellman's reagent. Anal Biochem 1968; 25: 192-205.
19. Marklund S, Marklund G. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 1974; 47: 469-474.
20. Aebi H. Catalase in vitro. Methods Enzymol 1984; 105: 121-126.
21. Paglia D E, Valentine W N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967; 70: 158-169.
22. Griffith O W. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal Biochem 1980; 106: 207-212. (Pubitemid 11246585)
23. Benzie I F F, Strain J J. The ferric reducing ability of plasma (FRAP) as a measure of 'antioxidant power': the FRAP assay. Anal Biochem 1996; 239: 70-76.
24. Rahman I, Skwarska E, MacNee W. Attenuation of oxidant/ antioxidant imbalance during treatment of exacerbations of chronic obstructive pulmonary disease. Thorax 1997; 52: 565-568. (Pubitemid 27298512)
25. Torres-Ramos Y D, García-Guillen M L, Olivares-Corichi I M, Hicks J J. Correlation of plasma protein carbonyls and C-reactive protein with GOLD stage progression in COPD patients. Open Respir Med J 2009; 3: 61-66.
26. Stadtman E R, Levine R L. Free radical-mediated oxidation of free amino acids and amino acid residues in proteins. Amino Acids 2003; 25: 207-218. (Pubitemid 38043943)
27. Ceylan E, Kocyigit A, Gencer M, Aksoy N, Selek S. Increased DNA damage in patients with chronic obstructive pulmonary disease who had once smoked or been exposed to biomass. Respir Med 2006; 100: 1270-1276. (Pubitemid 43793057)
28. Di Simplicio P, Cacace M G, Lusini L, Giannerini F, Giustarini D, Rossi R. Role of protein-SH groups in redox homeostasis the erythrocyte as a model system. Arch Biochem Biophys 1998; 355: 145-152. (Pubitemid 28364362)
29. Nadeem A, Raj H G, Chhabra S K. Increased oxidative stress and altered levels of antioxidants in chronic obstructive pulmonary disease. Inflammation 2005; 29: 23-32.
30. Van Asbeck B S, Hoidal J, Vercelloti G M, Schwartz B A, Moldow C F, Jacob H S. Protection against lethal hyperoxia by tracheal insufflation of erythrocytes: role of red cell glutathione. Science 1985; 227: 756-759. (Pubitemid 15168263)
31. Rai R R, Phadke M S. Plasma oxidant-antioxidant status in different respiratory disorders. Ind J Clin Biochem 2006; 21: 161-164. (Pubitemid 44756945)
32. Kluchova Z, Petrasova D, Joppa P, Dorkova Z, Tkacova R. The association between oxidative stress and obstructive lung impairment in patients with COPD. Physiol Res 2007; 56: 51-56.
33. Tsukamoto M, Tampo Y, Sawada M, Yonaha M. Paraquat- induced oxidative stress and dysfunction of the glutathione redox cycle in pulmonary microvascular endothelial cells. Toxicol Appl Pharmacol 2002; 178: 82-92. (Pubitemid 34135436)
34. Rahman I, Smith C A D, Lawson M F, Harrison D J, MacNee W. Induction of gamma-glutamyl cysteine synthetase by cigarette smoke is associated with AP-1 in human alveolar epithelial cells. FEBS Lett 1996; 396: 21-25. (Pubitemid 26360273)
35. Schunemann H J, Muti P, Freudenheim J L, et al. Oxidative stress and lung function. Am J Epidemiol 1997; 146: 939-948. (Pubitemid 27524281)